Books on the topic 'Cyclooxygenase'

Cyclooxygenases: Methods and protocols. New York, N.Y: Humana Press, 2010.

Meunier, Andreas. Cyclooxygenase-2 inhibitors and knee prosthesis surgery. Linköping: Department of Clinical and Experimental Medicine, Linköping University, 2008.

US-Italy Symposium on Cyclooxygenase and Lipoxygenase Modulators in Lung Reactivity (1984 Milan). Cyclooxygenase and lipoxgenase modulators in lung reactivity: US-Italy Symposium on Cyclooxygenase and Lipoxygenase Modulators in Lung Reactivity. Edited by Berti F, Hurd S, and Hegyeli R. J. 1931-. Basel: Karger, 1985.

R, Vane John, Botting Regina M, William Harvey Research Conference (1997 : Phuket, Thailand), and William Harvey Research Conference (1998 : Boston, Mass.), eds. Clinical significance and potential of selective COX-2 inhibitors: The combined proceedings of the William Harvey Conferences held in Phuket, Thailand, on 18-19 September, 1997 and in Boston, USA, on 23-24 April, 1998, supported by an educational grant from Boehringer Ingelheim. London: William Harvey Press, 1998.

Ayoub, Samir S., Roderick J. Flower, and Michael P. Seed, eds. Cyclooxygenases. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-59745-364-6.

Bandali, Karim Sadrudin. The role of the cyclooxygenase pathway in the cardiovascular and renal sympathoinhibitory effects of atrial natriuretic factor. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Masline, Shelagh Ryan. Celebrex: Cox-2 inhibitors--the amazing new pain fighters. New York: Avon Books, 1999.

Maetzel, Andreas. The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

H, Vandenburgh Herman, and United States. National Aeronautics and Space Administration., eds. Mechanical stimulation of skeletal muscle increases prostaglandin F[́alpha] synthesis and cyclooxygenase activity by a pertussis toxin sensitive mechanism. Providence, RI: Dept. of Pathology and Laboratory Medicine, Brown University School of Medicine and the Miriam Hospital, 1992.

The Cox-2 connection: Natural breakthrough treatment for arthritis, Alzheimer's, and cancer. Rochester, Vt: Healing Arts Press, 2001.

Andrzej, Szczeklik, Gryglewski Ryszard, and Vane John R, eds. Eicosanoids, aspirin, and asthma. New York: M. Dekker, 1998.

G, Bazán Nicolás, Botting Jack H, and Vane John R, eds. New targets in inflammation: Inhibitors of COX-2 or adhesion molecules : proceedings of a conference held on April 15-16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim. Dordrecht: Kluwer Academic Publishers, 1996.

Maetzel, Andreas. Economic assessment: Celecoxib and rofecoxib for patients with osteoarthritis or rheumatoid arthritis. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 2002.

Radi, Zaher A. Comparative Pathophysiology and Toxicology of Cyclooxygenases. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118351918.

Radi, Zaher A. Comparative pathophysiology and toxicology of cyclooxygenases. Hoboken, N.J: Wiley, 2012.

Radi, Zaher A. Comparative pathophysiology and toxicology of cyclooxygenases. Hoboken, N.J: Wiley, 2012.

E, Harris Randall, ed. Inflammation in the pathogenesis of chronic diseases: The COX-2 controversy. New York: Springer, 2007.

The arthritis solution: The newest treatments to help you live pain-free. New York: WholeCare, 1999.

Vane, John R. Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitors: Proceedings of a conference held on October 10-11, 1995, at Regent's College, London. Dordrecht: Kluwer Academic Publishers, 1996.

Barragry, Thomas B. N.S.A.I.D.S./toxicity: COX 2 developments. [Dublin]: [University College Dublin, Department of Small Animal Studies], 1998.

William Harvey Conference (1995 London, England). Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London. Dordrecht: Kluwer Academic, 1996.

Death of a dishonest man: Poems and prayers to Yogi Ramsuratkumar. Prescott, AZ: Hohm Press, 1999.

V, Honn Kenneth, Nigam S. K, Marnett Lawrence J, and International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury (3rd : 1993 : Washington, D.C.), eds. Eicosanoids and other bioactive lipids in cancer, inflammation, and radiation injury 2. New York: Plenum Press, 1997.

A, Lianos Elias, ed. Eicosanoid protocols. Totowa, N.J: Humana Press, 1999.

A, Willoughby D., and Tomlinson Annette 1942-, eds. Inducible enzymes in the inflammatory response. Basel: Birkhaüser, 1999.

Seed, Michael, Samir S. Ayoub, and Roderick J. Flower. Cyclooxygenases: Methods and Protocols. Humana Press, 2016.

Charames, George Shawn. Cyclooxygenase-2 knockdown in colon cancer by RNA interference. 2005.

Charames, George Shawn. Cyclooxygenase-2 knockdown in colon cancer by RNA interference. 2005.

Hendrickx, Nico. Mechanism & Role of Cyclooxygenase-2 Up-regulation by Photodynamic Therapy. Leuven University Press, 2006.

Vane, Sir John, ed. Clinical Significance And Potential Of Selective Cox-2 Inhibitors. WILLIAM HARVEY PRESS, 1998.

Ringbom, Therese. Bioassay Development for Identification of Cyclooxygenase-2 Inhibitors of Natural Origin. Uppsala Universitet, 2002.

Selective COX-2 inhibitors: Pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.

R, Vane John, Botting Jack H, and William Harvey Research Conference (1997 : Cannes, France), eds. Selective COX-2 inhibitors: Pharmacology, clinical effects and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.

Sir John R. Vane (Editor) and Jack H. Botting (Editor), eds. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 1998.

Botting, Jack H., and Sir John R. Vane. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 2012.

Studies on meloxicam (Mobic) a cyclooxygenase inhibitor with selectivity towards COX-2. Oxford: Oxford University Press, 1996.

Cyclooxygenase and Lipoxygenase Modulators in Lung Reactivity (Progress in Biochemical Pharmacology, Vol 20). S. Karger AG (Switzerland), 1985.

(Editor), Michel Pairet, and Joanne van Ryn (Editor), eds. COX-2 Inhibitors (Milestones in Drug Therapy). Birkhäuser Basel, 2004.

Kazior, Agnieszka. SN38, a topoisomerase 1 inhibitor, blocks activation of cyclooxygenase-2 in human cancer cells. 2003.

Masline, Shelagh R. Celebrex :: Cox-2 Inhibitors--the Amazing New Pain Fighters. Avon, 1999.

Howardell, Maynard J. Trends in Cox-2 Inhibitor Research. Nova Science Publishers, 2006.

Natural Alternatives To Vioxx, Celebrex & Other Anti-inflammatory Prescription Drugs. Square One Publishers, 2005.

Mechanical stimulation of skeletal muscle increases prostaglandin F[alpha] synthesis and cyclooxygenase activity by a pertussis toxin sensitive mechanism. Providence, RI: Dept. of Pathology and Laboratory Medicine, Brown University School of Medicine and the Miriam Hospital, 1992.

(Editor), Joseph R. Bertino, R. N. Dubois (Editor), and Andrew J. Dannenberg (Editor), eds. Cox-2: A New Target for Cancer Prevention and Treatment (Progress in Experimental Tumor Research). S. Karger Publishers (USA), 2003.

LaValle, James B. The Cox-2 Connection: Natural Breakthrough Treatments for Arthritis, Alzheimer's, and Cancer. Healing Arts Press, 2001.

Vane, John R., Andrzej Szczeklik, and Ryszard J. Gryglewski. Eicosanoids, Aspirin, and Asthma. Taylor & Francis Group, 1998.

Bazan, N., Jack H. Botting, and Sir John R. Vane. New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a Conference Held on April 15-16, 1996, in New Orleans, USA, Supported by an Educational Grant from Boehringer Ingelheim. Springer London, Limited, 2012.

Bazan, N., Jack H. Botting, and Sir John R. Vane. New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a Conference Held on April 15-16, 1996, in New Orleans, USA, Supported by an Educational Grant from Boehringer Ingelheim. Springer, 2012.

(Editor), N. Bazan, Jack H. Botting (Editor), and Sir John R. Vane (Editor), eds. New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules. Springer, 1996.

Elmofty, Dalia H. Opioid-Induced Hyperalgesia, Tolerance, and Chronic Postsurgical Pain: A Dilemma Complicating Postoperative Pain Management. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0037.